Rapport Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| EBT Margin | -99.29% | ||||||||
| EBIT Margin | -121.08% | ||||||||
| EBITDA Margin | -121.08% | ||||||||
| Operating Margin | -121.08% | ||||||||
| Net Margin | -99.29% | ||||||||
| FCF Margin | -65.74% | ||||||||
| Efficiency | |||||||||
| Assets AverageAssets Avg. | 338.62M | 323.04M | 308.49M | 293.77M | 410.41M | 523.88M | 505.01M | 478.29M | |
| Asset Utilization RatioAsset Util. | 0.04 | ||||||||
| Valuation | |||||||||
| Price to EarningsP/E | -13.69 | -42.71 | -18.41 | -15.21 | -15.52 | -41.84 | -34.99 | -75.33 | -35.30 |
| Price to SalesP/S | 74.79 | ||||||||
| Price to BookP/B | 0.74 | 2.32 | 1.20 | 1.28 | 1.57 | 2.20 | 2.44 | 3.17 | 4.72 |
| Enterprise Value | 137.83M | 709.67M | 62.62M | 308.36M | 359.81M | 351.89M | 690.74M | 620.37M | 1,562.21M |
| EV to EBIT | -6.63 | -32.79 | -2.66 | -11.38 | -12.20 | -11.74 | -17.94 | -25.62 | -25.69 |
| EV to EBITDA | -6.63 | -32.79 | -2.66 | -11.38 | -12.20 | -11.74 | -17.94 | -25.62 | -25.69 |
| Market Capitalization | 248.10M | 749.09M | 367.90M | 366.07M | 414.98M | 1,126.56M | 1,181.27M | 1,495.90M | 1,998.29M |
| Price to FCFP/FCF | -14.33 | -45.25 | -25.07 | -17.83 | -16.54 | -64.01 | -47.50 | -113.78 | -48.11 |
| EV to FCF | -7.96 | -42.87 | -4.27 | -15.02 | -14.34 | -19.99 | -27.77 | -47.19 | -37.61 |
| EV to CFO | -8.43 | -43.23 | -4.33 | -15.24 | -14.35 | -20.15 | -27.96 | -47.50 | -37.68 |
| Return Ratios | |||||||||
| Return on Sales [ROS]ROS | -121.08% | -767.58% | |||||||
| Return on Capital Employed [ROCE]ROCE | -22.42% | -26.43% | -31.12% | -36.10% | -27.80% | -24.78% | -25.09% | -34.12% | |
| Return on Assets [ROA]ROA | -19.03% | -21.95% | -25.84% | -30.06% | -23.81% | -21.28% | -21.24% | -28.68% |